tert-Butyl 3-(hydroxymethyl)-8-methyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate

Catalog No. :
ACXSRI115
CAS No. :
1445951-38-1
Molecular Formula :
C13H21N3O3
Molecular Weight :
267.33

IUPAC Name:tert-butyl 3-(hydroxymethyl)-8-methyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate

tert-Butyl 3-(hydroxymethyl)-8-methyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$680.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(hydroxymethyl)-8-methyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate
IUPAC Nametert-butyl 3-(hydroxymethyl)-8-methyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate
MDL No.MFCD25509359
Molecular FormulaC13H21N3O3
Molecular Weight267.33
SMILESO=C(N1C(C)C2=NC=C(CO)N2CC1)OC(C)(C)C
InChI KeyNQCDRTVKZMSHQL-UHFFFAOYSA-N
SynonymTert-Butyl 3-(Hydroxymethyl)-8-Methyl-5,6-Dihydroimidazo[1,2-A]Pyrazine-7(8H)-Carboxylate;Tert-Butyl 3-(Hydroxymethyl)-8-Methyl-5,6-Dihydroimidazo[1,2-A]Pyrazine-7(8H)-Carboxylate(WX141638);Imidazo[1,2-a]pyrazine-7(8H)-carboxylic acid, 5,6-dihydro-3-(hydroxymethyl)-8-methyl-, 1,1-dimethylethyl ester
CAS No.1445951-38-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXSRI115 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXSRI115 route product structure diagram
    ACXSRI1151445951-38-1
Inquiry

2. ACXSRI115 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXSRI115 route product structure diagram
    ACXSRI1151445951-38-1
Inquiry

Comments (0)